Literature DB >> 6787226

Quality of life in patients on permanent home parenteral nutrition.

K Ladefoged.   

Abstract

A psychosocial survey of patients on permanent home parenteral nutrition (HPN) has been made to assess the quality of life in these patients. All patients on permanent HPN in the period August 1978 to August 1979, including 7 women and 6 men, age range 24-62 yr (median 53) were interviewed, as well as partners of 11 patients who were married or cohabiting. The duration of HPN ranged from 2-43 mon (median 24 mon). They were asked specific questions about physical symptoms, social and leisure activities, interpersonal relationships, sexuality, psychological problems, and feelings about HPN. None had an outside job, but 6 (46%) did most of the housekeeping. Some physical distress was recorded in almost all patients, but 9 (69%) considered themselves healthy or fairly healthy, whereas 4 (31%) felt diseased. Social and leisure activities were normal or only slightly impaired in most. Sexual activity had ceased completely in 5 above 55 yr, in association with onset of the disease; younger patients displayed normal and unchanged sexual activity. Psychological symptoms were recorded in 6 (46%), major symptoms in 4 (31%). Seven partners considered HPN to be a moderate or severe burden, mainly psychological changes in the patient that caused marital tension in 3 cases. Criteria for quality of life were: 1) no major physical distress, 2) no major psychological symptoms, 3) no substantial restriction of social and leisure activities, 4) ability to accept HPN, 5) overall satisfaction with conditions of life. Nine patients who fulfilled at least 3 of these criteria were considered to have a fair quality of life, 4 who complied with less than 3 of the criteria a poor quality of life. The interviews were repeated at intervals of 6-10 mon in 9 patients, and revealed no systematic improvement or deterioration of quality of life during HPN.

Entities:  

Mesh:

Year:  1981        PMID: 6787226     DOI: 10.1177/0148607181005002132

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  8 in total

1.  Quality of life of patients on long-term total parenteral nutrition at home.

Authors:  A S Detsky; J R McLaughlin; H B Abrams; K A L'Abbe; J Whitwell; C Bombardier; K N Jeejeebhoy
Journal:  J Gen Intern Med       Date:  1986 Jan-Feb       Impact factor: 5.128

Review 2.  Quality of life of patients receiving home parenteral or enteral nutrition support.

Authors:  M Malone
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

3.  [Long-term parenteral nutrition in vascular-induced short bowel syndrome].

Authors:  M Gawenda; M Walter
Journal:  Langenbecks Arch Chir       Date:  1996

4.  Quality of life in patients receiving home parenteral nutrition.

Authors:  P B Jeppesen; E Langholz; P B Mortensen
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

Review 5.  No gut syndrome: near total enterectomy.

Authors:  Sergio Huerta; Sachin Kukreja; Kristen Carter; Dale Butler
Journal:  J Gastrointest Surg       Date:  2015-03-20       Impact factor: 3.452

6.  Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.

Authors:  P B Jeppesen; M Staun; L Tjellesen; P B Mortensen
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Surgical approach to short-bowel syndrome. Experience in a population of 160 patients.

Authors:  J S Thompson; A N Langnas; L W Pinch; S Kaufman; E M Quigley; J A Vanderhoof
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

8.  A Single Urine Sodium Measurement May Validly Estimate 24-hour Urine Sodium Excretion in Patients With an Ileostomy.

Authors:  Anne Kathrine Nissen Pedersen; Charlotte Rud; Trine Levring Wilkens; Mette Borre; Jens Rikardt Andersen; Jens Frederik Dahlerup; Christian Lodberg Hvas
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-04-15       Impact factor: 4.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.